open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-20
Get Citation

Diagnosis and treatment of female patients with lung cancer in IV stage

Irena Porębska, Bożena Weryńska, Monika Kosacka, Renata Jankowska

open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-20

Abstract

The prognosis of lung cancer is unfavorable. Five-year survival is achieved only 13% of patients. Most patients have advanced disease and require palliative treatment. The introduction of targeted therapy for the treatment of lung cancer is an important step associated with delay of disease progression while maintaining good life comfort during treatment. We present the case of a woman, in which the diagnostic difficulties were connected with the peripheral location of lung cancer. After the diagnosis, the patient was treated with erlotinib in the second line.

Abstract

The prognosis of lung cancer is unfavorable. Five-year survival is achieved only 13% of patients. Most patients have advanced disease and require palliative treatment. The introduction of targeted therapy for the treatment of lung cancer is an important step associated with delay of disease progression while maintaining good life comfort during treatment. We present the case of a woman, in which the diagnostic difficulties were connected with the peripheral location of lung cancer. After the diagnosis, the patient was treated with erlotinib in the second line.

Get Citation

Keywords

lung cancer, erlotinib, EGFR mutation

About this article
Title

Diagnosis and treatment of female patients with lung cancer in IV stage

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. G (2014)

Pages

20-24

Published online

2015-03-20

Keywords

lung cancer
erlotinib
EGFR mutation

Authors

Irena Porębska
Bożena Weryńska
Monika Kosacka
Renata Jankowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl